State Street Corp Biotechnology

State Street Corp

$2.47 Trillion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CGTX Cognition Therapeutics Inc	$8.4M	$91,000 0.0% of portfolio	121,850	Q4 2024 Added 94.18%
BCAB Bio Atla, Inc.	$11.6M	$89,000 0.0% of portfolio	151,377	Q4 2024 Added 8.43%
PASG Passage Bio, Inc.	$18M	$89,000 0.0% of portfolio	156,773	Q4 2024 Added 26.56%
CVM Cel Sci Corp	$10.8M	$86,000 0.0% of portfolio	215,207	Q4 2024 Added 11.21%
RANI Rani Therapeutics Holdings, Inc.	$28.7M	$85,000 0.0% of portfolio	62,442	Q4 2024 Added 48.52%
LEXX Lexaria Bioscience Corp.	$8.21M	$82,000 0.0% of portfolio	39,301	Q1 2024 New
NTRB Nutri Band Inc.	$39.4M	$79,000 0.0% of portfolio	17,266	Q3 2022 Added 16.66%
AIKI A Ikido Pharma Inc.	$20.8M	$76,000 0.0% of portfolio	20,086	Q3 2024 Added 0.5%
LTRN Lantern Pharma Inc.	$37M	$75,000 0.0% of portfolio	23,652	Q2 2024 Reduced 5.59%
ARMP Armata Pharmaceuticals, Inc.	$44.5M	$74,000 0.0% of portfolio	40,300	Q3 2023 New
DYAI Dyadic International Inc	$35M	$74,000 0.0% of portfolio	42,550	Q4 2024 Reduced 2.3%
OMGA Omega Therapeutics, Inc.	$957K	$71,000 0.0% of portfolio	94,730	Q2 2024 Reduced 80.33%
OCUP Ocuphire Pharma, Inc.	$20.2M	$69,000 0.0% of portfolio	70,473	Q4 2023 Added 33.29%
ATHA Athira Pharma, Inc.	$9.08M	$63,000 0.0% of portfolio	107,381	Q4 2024 Reduced 0.37%
RLYB Rallybio Corp	$8.03M	$59,000 0.0% of portfolio	62,072	Q3 2024 Reduced 4.83%
RLMD Relmada Therapeutics, Inc.	$8.3M	$55,000 0.0% of portfolio	106,735	Q4 2024 Added 7.56%
NXTC Next Cure, Inc.	$9.99M	$50,000 0.0% of portfolio	65,392	Q2 2024 Added 14.54%
EQ Equillium, Inc.	$16.1M	$47,000 0.0% of portfolio	59,720	Q2 2024 Added 13.49%
MIST Milestone Pharmaceuticals Inc.	$26.7M	$45,000 0.0% of portfolio	19,117	Q4 2024 Reduced 1.0%
GLYC Glycomimetics Inc	$11.5M	$44,000 0.0% of portfolio	179,265	Q1 2024 Reduced 4.02%
XLO Xilio Therapeutics, Inc.	$20.6M	$41,000 0.0% of portfolio	43,390	Q2 2024 Added 176.55%
RNXT Renovo Rx, Inc.	$9.25M	$37,000 0.0% of portfolio	26,152	Q2 2024 Added 38.72%
NERV Minerva Neurosciences, Inc.	$8.54M	$36,000 0.0% of portfolio	16,519	Q3 2023 Added 20.41%
ACXP Acurx Pharmaceuticals, Inc.	$4.28M	$35,000 0.0% of portfolio	43,466	Q1 2024 Added 52.16%
AIM Aim Immuno Tech Inc.	$1.92M	$34,000 0.0% of portfolio	173,103	Q1 2022 Added 7.91%
TPST Tempest Therapeutics, Inc.	$75.8M	$34,000 0.0% of portfolio	41,492	Q1 2024 Added 76.62%
BRTX Bio Restorative Therapies, Inc.	$6.39M	$28,000 0.0% of portfolio	20,459	Q1 2023 New
BTAI Bio Xcel Therapeutics, Inc.	$48.8M	$28,000 0.0% of portfolio	77,149	Q3 2024 Reduced 38.16%
BOLT Bolt Biotherapeutics, Inc.	$13.2M	$26,000 0.0% of portfolio	47,437	Q4 2023 Reduced 2.67%
RPTX Repare Therapeutics Inc.	$50.3M	$26,000 0.0% of portfolio	20,007	Q4 2024 Reduced 1.0%
SPRB Spruce Biosciences, Inc.	$2.83M	$24,000 0.0% of portfolio	60,700	Q4 2024 Reduced 5.75%
INAB In8 Bio, Inc.	$3.92M	$23,000 0.0% of portfolio	88,746	Q2 2024 Added 49.79%
EYEN Eyenovia, Inc.	$36.9M	$20,000 0.0% of portfolio	133,917	Q3 2024 Added 43.35%
INKT Mi Nk Therapeutics, Inc.	$245M	$17,000 0.0% of portfolio	25,515	Q2 2024 Reduced 0.32%
VINC Vincerx Pharma, Inc.	$5.3M	$15,000 0.0% of portfolio	57,016	Q1 2024 Added 32.16%
SNSE Sensei Biotherapeutics, Inc.	$12.6M	$12,000 0.0% of portfolio	25,774	Q2 2022 Reduced 88.57%
INDP Indaptus Therapeutics, Inc.	$3.96M	$11,000 0.0% of portfolio	13,073	Q1 2024 Reduced 32.87%
SILO Silo Pharma, Inc.	$3.36M	$11,000 0.0% of portfolio	12,500	Q1 2023 New
ONVO Organovo Holdings, Inc.	$15M	$10,000 0.0% of portfolio	27,831	Q2 2021 New
VIRX Viracta Therapeutics, Inc.	$751K	$10,000 0.0% of portfolio	65,867	Q4 2022 Added 11.51%
HCWB Hcw Biologics Inc.	$253M	$9,000 0.0% of portfolio	21,446	Q2 2022 Added 4.38%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	2,749,901	Q4 2024 Added 34.17%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.